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Oculocutaneous albinism (OCA) is a complex genetic disease with great clinical heterogeneity. Four different types
of OCA have been reported to date (OCA1, OCA2, OCA3, and OCA4). MATP was recently reported in a single
Turkish OCA patient as the fourth pathological gene, but no other patients with OCA4 have been reported. Here,
we report the mutational proﬁle of OCA4, determined by genetic analysis of the MATP gene in a large Japanese
population with OCA. Of 75 unrelated patients that were screened, 18 individuals (24%) were identiﬁed as having
OCA4; they harbored seven novel mutations, including four missense mutations (P58S, D157N, G188V, andV507L)
and three frameshift mutations (S90CGGCCArGC, V144insAAGT, and V469delG), showing that MATP is the
most frequent locus for tyrosinase-positive OCA in Japanese patients. We discuss the functional melanogenic activity
of each mutant allele, judging from the relationship between the phenotypes and genotypes of the patients. This
is the ﬁrst report on a large group of patients with OCA4.
Introduction
Oculocutaneous albinism (OCA) is a group of autoso-
mal recessive disorders caused by mutations of melan-
ogenic genes, including tyrosinase (for OCA1 [MIM
203100]) (Tomita et al. 1989), P protein (for OCA2
[MIM 203200]) (Rinchik et al. 1993), and tyrosinase-
related protein 1 (TYRP1) (for OCA3 [MIM 203290])
(Boissy et al. 1996). Individuals with OCA1A are born
with a complete absence of pigment in the hair, eyes,
and skin. In patients with OCA1B and OCA2, the phe-
notypes are typically somewhat less severe than in those
associated with OCA1A, and the two disorders display
considerable clinical overlap (Lee et al. 1994). The
OCA3 phenotype is characterized by reddish skin and
hair color in African blacks and is caused by a mutation
in TYRP1. Rufous OCA is now classiﬁed as OCA3
(Manga et al. 1997). Recently, a novel melanogenic gene
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located in chromosome segment 5p and named “MATP”
(membrane-associated transporter protein) or “AIM-1”
(antigen in melanoma-1) was identiﬁed as the fourth
pathological OCA gene. The human MATP gene en-
codes a 530–amino-acid polypeptide that contains 12
putative transmembrane domains, exhibits structural
homology to plant sucrose-proton symporters, and is
expressed in a high percentage of melanoma cell lines
(Harada et al. 2001). Its homolog in medaka ﬁsh, b,
encodes a transporter that mediates melanin synthesis
(Fukamachi et al. 2001). In a single Turkish patient with
OCA, a homozygous G-to-A transition in the splice-
acceptor sequence of exon 2 of the MATP gene was
identiﬁed, and that type of OCA was termed “OCA4”
(MIM 606574) (Newton et al. 2001). No other patient
with OCA4 was subsequently reported, suggesting that
OCA4 might be a very minor type of OCA in the world-
wide OCA population. Little is known about the clinical
phenotype of OCA4, although the Turkish patient with
generalized hypopigmentation and ocular abnormalities
was reported to be within the phenotypic range com-
monly associated with OCA2 (Newton et al. 2001).
We examined 75 Japanese patients with OCA, in
which 35 (47%) and 6 (8%) were classiﬁed as having
OCA1 and OCA2, respectively, according to the se-
quence analyses of the tyrosinase gene and the P gene
(Tomita et al. 2000; Suzuki et al. 2003). The remaining
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Table 1






1 (5′ side) 5′-AGGCTCCACGTCAAATCCAG-3′ 5′-GGTCACATACGCTGCCTCCA-3′ 260
1 (middle) 5′-CAGACTCATCATGCACAGCA-3′ 5′-ATGCCCACGAGCATCATGAC-3′ 252
1 (3′ side) 5′-CAGCATTGTGTGGTTCCTCA-3′ 5′-GGTCAAACACATGAACATCCTC-3′ 261
2 5′-AACGTGGATGATTCTAAAACAGGA-3′ 5′-CTCATTGTCTGGGGAGCTGA-3′ 280
3 (5′ side) 5′-GGGAGTGTCTATGCATGAGG-3′ 5′-GATAGAACCATACTCGTACATTCC-3′ 324
3 (3′ side) 5′-GCCCCACTTACAGAGGTTGC-3′ 5′-CAACAAAGAGCAAGAATATTTTCCCTTG-3′ 224
4 5′-AGCTGGCTGAGTTTCTGCAG-3′ 5′-CCTCAACAGGTGTTAATGGAGG-3′ 265
5 5′-AGAGGTGGAGAAGCAGAGTG-3′ 5′-GAAGACATCCTTAGGAGAGAG-3′ 236
6 5′-ATGAGGCACTGCCAGCTGTA-3′ 5′-CCCAAGGCAGAGGTTCAATG-3′ 286
7 5′-GCCCTAAATGACAGTTCCTTG-3′ 5′-TGTGCTTCACTGTCTCTGAG-3′ 326
34 patients were further examined to see whether any
of them had MATP mutations. In this study, we report
18 individuals who have been identiﬁed with OCA4.
Subjects and Methods
Patients
A total of 34 Japanese patients with OCA (20 females
and 14 males), who were unrelated and in whom no mu-
tation in either the tyrosinase gene or the P gene was
detected, were included in this study. The degree of hypo-
pigmentation in each patient varied from mild to severe,
similar to tyrosinase-relatedOCA (OCA1A andOCA1B).
No patient had a family history of inbreeding.
This study was approved by the ethics committee of
the Nagoya University School of Medicine. Informed
consent was obtained from each patient, or from the
patient’s parents, in the case of children.
Identiﬁcation of the Genomic Organization and
Mutation Screening of the MATP Gene
The GenBank database was screened with the MATP
complementary DNA sequence (AF172849). From one
human genomic contig (NT_023085), the intron/exon
boundaries of theMATP gene were analyzed, and primer
sequences were designed for the mutation screening of
the MATP gene (table 1). Genomic DNA was isolated
from the peripheral blood of each patient by use of a
genomic DNA puriﬁcation kit (Qiagen). The human
MATP gene spans 7 exons. In exon 1, three primer sets
were designed—for the 5′ side, the middle part, and the
3′ side—because DNA fragments 1350 bp were not suit-
able to detect mutations precisely in our system. In exon
3, two primer sets were designed, for the same reason
as in exon 1. The ampliﬁed fragments were then screened
for mutations by simultaneous analyses of SSCPs and
the heteroduplex method (Spritz et al. 1992). Three
kinds of SSCP gels, with glycerol concentrations of 0%,
7%, and 10%, were used to elevate the sensitivity of
our mutation screening system. Standard PCR ampliﬁ-
cation procedures were employed, with an annealing
temperature of 58C for all primers, except the primer
sets for exons 3 and 5, which were done at 61C. PCR
products showing aberrant patterns were reampliﬁed
and sequenced directly. In patients with one or no mu-
tations detected by the SSCP method, all of their PCR
products were directly sequenced to identify any
mutations.
Results and Discussion
Mutations of the MATP Gene
Among the 75 Japanese patients with OCA in our
study, 34 patients lacked any mutation in the coding or
adjacent noncoding sequences of the tyrosinase gene or
the P gene. The diagnoses of OCA1 orOCA2were there-
fore essentially eliminated. We then screened for muta-
tions in the MATP gene of those 34 patients with OCA.
PCR-SSCP/heteroduplex screening and direct sequenc-
ing of the MATP gene ﬁnally detected seven novel mu-
tations in 18 individuals (3 males and 15 females) (table
2). These novel mutations included four missense sub-
stitutions (P58S, D157N, G188V, and V507L), two de-
letion mutations (S90CGGCCArGC and V469delG),
and one insertion mutation (V144insAAGT). All of the
four missense mutations were found at amino acid res-
idues conserved among medaka ﬁsh, mouse, and human.
We examined the frequency of the sevenmutant alleles
in the MATP gene of 104 unrelated normally pigmented
Japanese subjects (208 alleles), and no mutant allele was
detected (table 3). This indicates that those seven alleles
might be very rare in the general Japanese population
and could be deﬁned statistically as pathological alleles.
In six patients (4, 11, 15, 19, 20, and 25 [table 2]),
only one heterozygous mutation was found, although
we directly sequenced all PCR products ampliﬁed from
the DNA of these six patients to ﬁnd a second mutation.
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Table 2
Mutations of the MATP Gene in 18 Japanese Patients with OCA4
PATIENT AGE SEX
MUTATION CLINICAL PHENOTYPE PARENTS
1st 2nd Hair Color Iris Color Nystagmus Mother Father
3 23 years F D157N G188V Light yellow Blue Positive G188V D157N
4 1 year M G188V NI Brown Red-brown Negative NM G188V
6 13 years F D157N V469delG Light yellow Blue Positive V469delG D157N
8 71 years F D157N D157N White Blue Positive ND ND
9 25 years F S90CGGCCArGC V144insAAGT White Blue Positive ND ND
10 1 year F G188V S90CGGCCArGC Blond Gray-blue Negative G188V S90CGGCCArGC
11 25 years F D157N NI Blond Brown Negative ND NM
12 5 years M G188V G188V Pale blond Red-brown Negative G188V G188V
15 11 mo F G188V NI Light yellow Brown Negative G188V NM
17 1 year F D157N G188V Yellow Blue Positive G188V D157N
19 10 years F D157N NI Brown-black Brown Negative ND ND
20 2 mo F D157N NI Light yellow Gray-blue Negative D157N NM
25 6 years F D157N NI Blond Gray Positive D157N NM
36 1 year F D157N V507L Blond Gray-blue Negative V507L D157N
38 1 mo M D157N V144insAAGT Light yellow Gray Positive D157N V144insAAGT
42 6 mo F P58S S90CGGCCArGC Light yellow Blue Negative P58S S90CGGCCArGC
50 24 years F D157N D157N Light yellow Blue Positive D157N ND
51 1 year F D157N S90CGGCCArGC Light yellow Blue Positive D157N S90CGGCCArGC
NOTE.—ND p an examination was not done; NM p no mutation was found in our examination; NI p mutation not identiﬁed.
It seems likely that the other MATP allele contains an
occult mutation that either was not detected by our
SSCP/heteroduplex screening procedure or occurs in a
gene region not sampled in the PCR products.
The frequency of OCA4 in the Japanese albino pop-
ulation was 24% (18/75), indicating that mutations in
the MATP gene are one of the most common causes of
tyrosinase-positive OCA in Japan. Although all PCR
products ampliﬁed from their DNA were directly se-
quenced to ﬁnd any mutations in the MATP gene, 16
patients still remained as an unclassiﬁed type of OCA.
Of the four missense mutations identiﬁed, three were
within transmembrane domains and one was the ﬁrst
amino acid in the second cytoplasmic loop (table 3). This
is in complete contrast to mutations of the P protein
associated with OCA2, because most missense substi-
tutions in patients with OCA2 occurred within the loops
between the transmembrane domains (Spritz 1994).
Both the MATP and the P proteins have 12 transmem-
brane domains arranged similarly to various transport-
ers and appear to be integral membrane proteins of
melanosomes.
Identiﬁcation of Polymorphism
SSCP revealed several polymorphisms in the exonic
or the nearby intronic sequences in the MATP gene, and
the frequencies were determined for the 34 patients with
OCA and the 104 unrelated normally pigmented Japa-
nese subjects (table 4). Two of the exonic polymorphisms
resulted in amino acid changes (E272K and T500P),
whereas the remaining ones were silent. E272K is a com-
mon polymorphism (0.37), whereas T500P is rare (0.01)
in the Japanese population. Three of the polymorphisms
(IVS314ArG [MATP1-1; dbSNP accession number
ss16339967], IVS4-6TrC [MATP1-2; dbSNP accession
number ss16339968], and A1498C [MATP1-3; dbSNP
accession number ss16339969]) were novel.
The Relationship between the Genotype and the
Phenotype in Patients with OCA4
The Pro(CCA)58Ser(TCA) mutation in exon 1 oc-
curred within the ﬁrst transmembrane domain (table 3)
and was identiﬁed only in patient 42. The othermutation
in that patient was a S90CGGCCArGC frameshift mu-
tation, which creates a stop codon at 111 and thus pro-
duces no functional protein. Patient 42 was a 6-mo-old
girl with light yellow hair and blue irides.
The Asp(GAC)157Asn(AAC) mutation in exon 2
causes a substitution from an acidic to a neutral amino
acid at the ﬁrst residue in the second cytoplasmic loop.
This mutant allele was found in 12 patients, and 2 of
them (patients 8 and 50) were homozygous for this al-
lele. The allele frequency of D157N in all patients with
OCA4 was 0.39 (14/36), indicating that D157N is the
most common mutant allele in Japanese patients with
OCA4. Patient 8 was 71 years old with nystagmus and
had no pigmentation in her hair or eyes. Patient 50, who
was 24 years old, also showed light yellow hair and blue
irides with nystagmus. Patients 6, 38, and 51 (ﬁg. 1B)
had the D157N allele plus another mutant allele—
V469delG, V144insAAGT, or S90CGGCCArGC, re-
spectively—which may have no functional activity in
melanogenesis because themutations caused frameshifts.
All of those patients presented with light yellow hair,
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Figure 1 The diverse clinical phenotypes of patients with OCA4. Both patients are 1-year-old Japanese girls. Patient 36, with D157N
and V507L mutations, has blond hair and gray-blue irides (A). Patient 51, with D157N and S90CGGCCArGC mutations, has light yellow
hair and blue irides (B). Note the milder hypopigmentation of patient 36 compared with that of patient 51.
blue eyes, and nystagmus, as did patients 8 and 50. These
results indicate that the D157Nmutant allele might have
a very low functional activity in melanogenesis.
The Gly(GGT)188Val(GTT) mutation resulted from
a single-nucleotide mutation from G to T at the ﬁrst
nucleotide of exon 3, which caused an amino acid sub-
stitution within the ﬁfth transmembrane domain (table
3). This mutant allele was found in six patients, includ-
ing one homozygote for this allele (patient 12). The allele
frequency was 0.19 (7/36). The clinical phenotype of
patient 12 presented with some pigmentation—that is,
the hair was pale blond, and the irides were red-brown
without nystagmus. Patient 10, who had the G188V
allele and the S90CGGCCArGC allele, presented with
blond hair and gray-blue eyes. All other patients who
had the G188V allele also presented with some gener-
alized pigmentation (patients 3, 4, 15, and 17), although
the degree of hypopigmentation in each patient varied.
These results indicate that the G188V allele might have
some functional activity in melanogenesis.
The Val(GTG)507Leu(CTG) mutation in exon 7 oc-
curred within the 12th transmembrane domain, which
is nearest to the C-terminal of the MATP protein. A
single individual (patient 36 [ﬁg. 1A]) had this mutant
allele and presented with blond hair and gray-blue irides.
Her other mutant allele was D157N, which appears to
have a very low functional activity in melanogenesis, as
mentioned above.
Three different frameshift mutations were identiﬁed in
this study. The ﬁrst one was found in four patients (9,
10, 42, and 51) who exhibited clear heteroduplexes on
SSCP gels with the primer set for exon 1; the consequent
sequencing revealed a two-plus-two nucleotide deletion
(CGGCCArGC) from Ser90 to Ser92. This deletion re-
sults in a change after amino acid 90 with a consequent
truncation of the distal MATP nonsense polypeptide, so
that 21 new amino acids were translated before a pre-
mature stop occurred at codon 111. The second frame-
shift mutation was observed in two patients (9 and 38)
who have a 4-bp insertion in exon 2 (V144insAAGT),
which results in a 10–amino-acid frameshift followed by
a premature stop at codon 154. A single nucleotide de-
letion of G in exon 7 (V469delG) was identiﬁed as the
third frameshift mutation in one individual (patient 6).
This deletion results in a frameshift with a truncation of
the MATP nonsense polypeptide at codon 469 that lacks
the C-terminal 2 transmembrane domains of the predicted
protein. Patient 9 had two different frameshift mutation
alleles, S90CGGCCArGC andV144insAAGT,which are
both predicted to have no functional activity in melan-
ogenesis. This patient was 25 years old and had no gen-
eralized pigmentation, a phenotype similar to OCA1A
(tyrosinase-negative OCA). Therefore, it was impossible
to distinguish her or patient 8 from patients withOCA1A
on the basis of their clinical phenotypes. However, we
could have identiﬁed her as non-OCA1A with a positive
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Table 3
Positions of MATP Gene Mutations Identiﬁed in This Study and Its Frequencies in Japanese Patients with
OCA4 and Normally Pigmented Japanese Subjects
PATHOGENIC
VARIANT POSITION IN THE MATP PROTEIN







P58S 1st transmembrane domain 1 (.03) 0
D157N 2nd cytoplasmic loop 14 (.39) 0
G188V 5th transmembrane domain 7 (.19) 0
V507L 12th transmembrane domain 1 (.03) 0
S90CGGCCArGC Frameshift in 1st cytoplasmic loop 4 (.11) 0
V144insAAGT Frameshift in 4th transmembrane domain 2 (.06) 0
V469delG Frameshift in 5th cytoplasmic loop 1 (.03) 0
NOTE.—n p number of alleles.
Table 4
Polymorphisms Detected in the MATP Gene and Its Frequencies in Japanese










G814A E272K EX3 30/68 (.44) 76/208 (.37)
IVS314ArG None IVS3 1/68 (.01) 0/208 (.00)
G987A T329T EX4 18/68 (.26) 57/208 (.27)
IVS4-6TrC None IVS4 1/68 (.01) 0/208 (.00)
IVS4-44ArC None IVS4 34/68 (.50) 129/208 (.62)
A1498C T500P EX7 0/68 (.00) 2/208 (.01)
G1594A None EX7 0/68 (.00) 1/208 (.005)
a Nucleotide 1 begins at the ﬁrst nucleotide of codon 1.
DOPA test by use of electron microscopy, because her
specimen showed stage IV melanosomes when treated
with DOPA, indicating that the tyrosinase activity in her
melanosomes was fairly high (data not shown).
Finally, we speculate that the D157N allele might sup-
press the functional activity of the G188V allele on me-
lanogenesis, similar to the amino acid substitution of
D153N in the mouse underwhite gene of Uwdbr, which
is known as a dominant allele that reduces melanoge-
nesis when heterozygous (Sweet et al. 1998; Newton et
al. 2001). Patient 10, whose clinical phenotype included
blond hair and gray-blue irides without nystagmus, had
both the G188V and the S90CGGCCArGC mutant al-
leles. On the other hand, patients 3 and 17, who had
the D157N and the G188V mutation alleles, respec-
tively, presented with yellow hair and blue irides with
nystagmus, showing somewhat more severe hypopig-
mentation than patient 10. This may suggest that
D157N might have a dominant negative effect, because
the MATP mutant protein derived from the G188V mu-
tant allele appeared to have some functional activity in
melanogenesis by itself, as mentioned above. More ad-
vanced approaches for functional assays will be required
to conﬁrm the dominant negative effect of the D157N
substitution on melanogenesis, because other differing
background genes in these patients may contribute to
their more severe hypopigmentation.
In conclusion, this study demonstrates that seven
novel mutations in the MATP gene were found in 18
Japanese patients with OCA, indicating that OCA4 is
one of the major types in Japan. The study also estab-
lishes that the clinical phenotype of the patients varied,
depending on their mutant genotypes. Further accu-
mulation of data correlating phenotypes with mutant
genotypes is expected to give new insights into investi-
gations on melanogenesis.
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